Visit COVID-19 resources

[Skip to Content]

Drug targeting in Acanthamoeba keratitis: rational of using drugs that are already approved for ocular use in non-keratitis indications – (Drug targeting in Acanthamoeba keratitis: rational of using drugs that are already approved for ocular use in non-keratitis indications, Published online: 2018-10-24; | doi:10.1038/s41433-018-0245-6)

24 October 2018

This news item is available to RCOphth members only, please log in below to access.

Members Login